Published in Cancer Invest on January 01, 2005
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet (1998) 12.92
Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol (2000) 2.58
Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol (2000) 2.28
Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett (1995) 2.19
Optimized dose planning of radioiodine therapy of benign thyroidal diseases. J Nucl Med (1993) 2.12
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res (2001) 2.06
[Sialidase activity in cervical connective tissue during cervix maturation and dilatation during labor]. Orv Hetil (1994) 2.04
Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology (1999) 1.98
Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res Hum Retroviruses (1995) 1.92
Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. Eur J Cancer (2002) 1.77
S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke (1997) 1.76
Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype. Ann Neurol (1999) 1.74
Removal of constricting bands using the Dremel drill. Acad Emerg Med (1999) 1.57
Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy. Ann Oncol (2003) 1.53
Preoperative evaluation of ovarian tumors in the premenopause by transvaginosonography. Am J Obstet Gynecol (1996) 1.48
Changes in local cerebral glucose utilization in the awake rat during acute and chronic administration of ethanol. J Nucl Med (1993) 1.42
Optimized differential diagnosis of breast lesions by combined B-mode and color Doppler sonography. Ultrasound Obstet Gynecol (1997) 1.41
[Laparoscopic preliminary surgery of ovarian malignancies. Experiences from 127 German gynecologic clinics]. Geburtshilfe Frauenheilkd (1995) 1.41
Improved automated leucocyte counting and differential in newborns achieved by the haematology analyser CELL-DYN 3500. Clin Lab Haematol (1995) 1.40
[Diagnosis of early extrauterine pregnancy by serum and Douglas pouch fluid hCG level]. Geburtshilfe Frauenheilkd (1991) 1.40
Nicotine receptor mapping. Eur J Nucl Med (1996) 1.39
Disseminated bone marrow metastases from primary breast cancer: detection and follow-up by radioimmune bone marrow scintigraphy. J Nucl Med (1994) 1.38
2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer (2001) 1.30
Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am J Pathol (1995) 1.23
Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med (2000) 1.23
Facial expression recognition in people with medicated and unmedicated Parkinson's disease. Neuropsychologia (2003) 1.23
Sequence determination of the 3' end of mouse mammary tumor virus RNA. Mol Biol Rep (1981) 1.21
Disgust implicated in obsessive-compulsive disorder. Proc Biol Sci (1997) 1.19
Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer. Gynecol Oncol (2001) 1.16
Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor. Eur J Obstet Gynecol Reprod Biol (1997) 1.15
Interleukin-8 synthesis and the onset of labor. Obstet Gynecol (1995) 1.12
Diagnosis of early ectopic pregnancy by measurement of the maternal serum to cul-de-sac fluid beta-hCG ratio. Ultrasound Obstet Gynecol (1995) 1.12
Standardized uptake values of fluorine-18 fluorodeoxyglucose: the value of different normalization procedures. Eur J Nucl Med (1996) 1.12
Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease. Acta Neurol Scand (1998) 1.10
Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back? Breast (2007) 1.10
Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers. Neurology (2001) 1.09
Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol (1997) 1.09
Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose. Eur Urol (1999) 1.09
Glycosaminoglycans in cervical connective tissue during pregnancy and parturition. Obstet Gynecol (1993) 1.08
Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients. Eur J Nucl Med Mol Imaging (2013) 1.08
Brain single-photon emission tomography using technetium-99m bicisate (ECD) in a case of complex partial seizure. Eur J Nucl Med (1994) 1.07
Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med (1999) 1.06
FDG-PET findings of vertebral compression fractures in osteoporosis: preliminary results. Osteoporos Int (2002) 1.05
The N-methyl-D-aspartate antagonist memantine retards progression of Huntington's disease. J Neural Transm Suppl (2004) 1.04
Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide. Eur J Nucl Med (2000) 1.02
Origin of cervical collagenase during parturition. Am J Obstet Gynecol (1992) 1.02
Technetium-99m-MIBI scintimammography for suspicious breast lesions. J Nucl Med (1996) 1.02
Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results. Eur Spine J (2001) 1.02
[13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia (1996) 1.01
Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography. Anticancer Res (2005) 1.01
[Preventing complications due to dilatation by intracervical application of a prostaglandin-gel (author's transl)]. Geburtshilfe Frauenheilkd (1977) 1.01
Identification of proteins from human cerebrospinal fluid, separated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis (2000) 1.00
Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2. Cancer Res (1995) 0.98
Radical surgical procedure improves survival time in patients with recurrent ovarian cancer. Cancer (1992) 0.98
[Indications for nuclear medicine therapy in advanced prostate carcinoma]. Urologe A (1998) 0.98
[Prevention of habitual abortion by buffycoat transfusions]. Z Geburtshilfe Perinatol (1986) 0.98
Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. Neuroreport (2000) 0.98
Prognostic impact of tumor biological factors on survival in node-negative breast cancer. Anticancer Res (1998) 0.97
Induction of transmissible lymphomas in Syrian hamsters by application of DNA from viral hamster papovavirus-induced tumors and by cell-free filtrates from human tumors. Proc Natl Acad Sci U S A (1969) 0.97
Resident self-scheduling: a painful method of reinventing the wheel. Acad Emerg Med (2000) 0.96
Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging. Eur J Nucl Med (1996) 0.96
Cystatin C-based calculation of glomerular filtration rate in kidney transplant recipients. Kidney Int (2006) 0.96
Genetic analysis of immunomodulating factors in sporadic Parkinson's disease. J Neural Transm (Vienna) (2000) 0.95
Nigral endothelial dysfunction, homocysteine, and Parkinson's disease. Lancet (1999) 0.95
FDG-PET imaging for the staging and follow-up of small cell lung cancer. Eur J Nucl Med (2001) 0.94
A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer. J Clin Invest (1993) 0.94
[Scintigraphically "hot" thyroid nodules mainly go hand in hand with a normal TSH]. Nuklearmedizin (2011) 0.94
[Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors]. Urologe A (1998) 0.94
Redifferentiation therapy-induced radioiodine uptake in thyroid cancer. J Nucl Med (1998) 0.93
Pre-clinical experience with Re-188-RC-160, a radiolabeled somatostatin analog for use in peptide-targeted radiotherapy. Anticancer Res (1997) 0.93
Sedimentation analysis of conformation changes of circular PM 2 DNA in relation to the ionic strength. Biochim Biophys Acta (1971) 0.93
188Re- and 99mTc-MAG3 as prosthetic groups for labeling amines and peptides: approaches with pre- and postconjugate labeling. Nucl Med Biol (1998) 0.93
EGF-R and overexpression of the oncogene c-erbB-2 in ovarian cancer: immunohistochemical findings and prognostic value. J Obstet Gynaecol (Tokyo 1995) (1995) 0.93
Correlation between tapping and inserting of pegs in Parkinson's disease. Can J Neurol Sci (2000) 0.93
In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells. Proc Natl Acad Sci U S A (1999) 0.93
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours. Eur J Nucl Med (1997) 0.92
Chronic intoxication with lead- and sulfur compounds may produce Parkinson's disease. J Neural Transm Suppl (1995) 0.92
The corpus luteum insufficiency: a multifactorial disease. J Clin Endocrinol Metab (1996) 0.92
Osteoporosis in haemophilia - an underestimated comorbidity? Haemophilia (2007) 0.92
Absence of foamy virus DNA in Graves' disease. AIDS Res Hum Retroviruses (1994) 0.91
FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. J Nucl Med (2000) 0.91
Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment. Anticancer Res (1997) 0.91
FDG-PET in monitoring therapy of breast cancer. Eur J Nucl Med Mol Imaging (2004) 0.91
Prognostic value of transvaginal sonography in asymptomatic endometrial cancers. Ultrasound Obstet Gynecol (1995) 0.91
Cerebral perfusion during transient global amnesia: findings with HMPAO SPECT. J Nucl Med (1998) 0.90
Studies on the quality of breast milk during 23 months of lactation in a rural community of the Ivory Coast. Am J Clin Nutr (1979) 0.90
D-Arg-[Hyp3-D-Phe7]-bradykinin, a bradykinin antagonist, reduces mortality in a rat model of endotoxic shock. Circ Shock (1989) 0.90
Functional and morphological abnormalities in temporal lobe epilepsy: a comparison of interictal and ictal EEG, CT, MRI, SPECT and PET. J Neurol (1987) 0.90
The sensory tensor fasciae latae flap: a 9-year follow-up. Ann Plast Surg (1991) 0.90
[Puerperal ovarian vein thrombophlebitis--a rare puerperal complication]. Geburtshilfe Frauenheilkd (1988) 0.90
Wideband harmonic imaging: a novel contrast ultrasound imaging technique. Eur Radiol (1999) 0.90
Extrapyramidal features in central Lyme borreliosis. Eur Neurol (1989) 0.89
Biochemical events in cervical ripening dilatation during pregnancy and parturition. J Obstet Gynaecol (Tokyo 1995) (1995) 0.89
Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases. Eur J Nucl Med (2000) 0.89
Repeat intrathecal triamcinolone acetonide application is beneficial in progressive MS patients. Eur J Neurol (2006) 0.89
Experimental radiotherapy of receptor-positive human prostate adenocarcinoma with 188Re-RC-160, a directly-radiolabeled somatostatin analogue. Int J Cancer (1996) 0.89
Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer. Anticancer Res (1997) 0.89